{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:07:20Z","timestamp":1758632840903},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:00:00Z","timestamp":1382659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s12185-013-1454-1","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T05:55:03Z","timestamp":1382594103000},"page":"716-718","source":"Crossref","is-referenced-by-count":7,"title":["Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab"],"prefix":"10.1007","volume":"98","author":[{"given":"Suresh K.","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hillmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise M.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma L.","family":"Brooksbank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Scarsbrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mervyn H.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"key":"1454_CR1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.jbchem.a021746","volume":"122","author":"T Kinoshita","year":"1997","unstructured":"Kinoshita T, Ohishi K, Takeda J. GPI-anchor synthesis in mammalian cells: genes, their products, and a deficiency. J Biochem. 1997;122:251\u20137.","journal-title":"J Biochem"},{"key":"1454_CR2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0950-3536(89)80010-1","volume":"2","author":"B Rotoli","year":"1989","unstructured":"Rotoli B, Luzzatto L. Paroxysmal nocturnal hemoglobinuria. Baillieres Clin Haematol. 1989;2:113\u201338.","journal-title":"Baillieres Clin Haematol"},{"key":"1454_CR3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","volume":"333","author":"P Hillmen","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. New Engl J Med. 1995;333:1253\u20138.","journal-title":"New Engl J Med"},{"key":"1454_CR4","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, et al. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 2011;117:6786\u201392.","journal-title":"Blood"},{"key":"1454_CR5","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extra cellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653\u201362.","journal-title":"JAMA"},{"key":"1454_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.2007.06554.x","volume":"137","author":"A Hill","year":"2007","unstructured":"Hill A, Richards SJ, Hillmen P. Recent developments in the understanding and Management of paroxysmal nocturnal hemoglobinuria. Br J Haematol. 2007;137:181\u201392.","journal-title":"Br J Haematol"},{"key":"1454_CR7","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699\u2013709.","journal-title":"Blood"},{"key":"1454_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2141.2004.04992.x","volume":"126","author":"VM Mayo","year":"2004","unstructured":"Mayo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal hemoglobinuria using modern diagnostic assays. Br J Haematol. 2004;126:133\u20138.","journal-title":"Br J Haematol"},{"key":"1454_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000126763.68170.46","volume":"83","author":"J Nishimura","year":"2004","unstructured":"Nishimura J, Kanakura Y, Ware RE, Shichishima T, Nakakuma H, Ninomiya H, et al. Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore). 2004;83:193\u2013207.","journal-title":"Medicine (Baltimore)"},{"key":"1454_CR10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","volume":"348","author":"G Soci\u00e9","year":"1996","unstructured":"Soci\u00e9 G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal hemoglobinuria: long-term follow-up and prognostic factors. Lancet. 1996;348:573\u20137.","journal-title":"Lancet"},{"key":"1454_CR11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","volume":"33","author":"TC Thomas","year":"1996","unstructured":"Thomas TC, Rollins SA, Rother RP, Giannoni MA, Hartman SL, Elliott EA, et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol. 1996;33:1389\u2013401.","journal-title":"Mol Immunol"},{"key":"1454_CR12","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1182\/blood-2008-11-189944","volume":"113","author":"AM Risitano","year":"2009","unstructured":"Risitano AM, Notaro R, Marando L, Serio B, Ranaldi D, Seneca E, et al. Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood. 2009;113:4094\u2013100.","journal-title":"Blood"},{"key":"1454_CR13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3324\/haematol.2009.007229","volume":"95","author":"A Hill","year":"2010","unstructured":"Hill A, Rother RP, Arnold L, Kelly R, Cullen MJ, Richards SJ, et al. Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extra vascular hemolysis occurring through C3 opsonisation. Haemtologica. 2010;95:567\u201373.","journal-title":"Haemtologica"},{"key":"1454_CR14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2008-04-151613","volume":"112","author":"AM Risitano","year":"2008","unstructured":"Risitano AM, Marando L, Seneca E, Rotoli B. Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab. Blood. 2008;112:449\u201351.","journal-title":"Blood"},{"key":"1454_CR15","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","volume":"111","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, et al. Multicentre phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008;111:1840\u20137.","journal-title":"Blood"},{"key":"1454_CR16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2141.2012.09146.x","volume":"158","author":"F Rodeghiero","year":"2012","unstructured":"Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign hematological disorders: should we revisit the indications? Br J Haematol. 2012;158:16\u201329.","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1454-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-013-1454-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1454-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:11:15Z","timestamp":1559452275000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-013-1454-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1007\/s12185-013-1454-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,25]]}}}